FIGURE 2.

Results of a secondary meta‐analysis. D2 partial agonists were compared with the placebo. Colors indicate the presence or absence of a significant difference: blue, drug was superior to placebo; black, drug was similar to placebo; red, drug was inferior to placebo. The order of treatments is according to the mean effect size. 95% CI, 95% confidence interval; AE, adverse event; ARI, aripiprazole; BRE, brexpiprazole; D2PA, dopamine D2 partial agonist; MADRS, Montgomery Åsberg Depression Rating Scale; OR, odds ratio; PLA, placebo; SMD, standardized mean difference.